These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9219147)

  • 1. A controlled trial of imipramine for the treatment of methamphetamine dependence.
    Galloway GP; Newmeyer J; Knapp T; Stalcup SA; Smith D
    J Subst Abuse Treat; 1996; 13(6):493-7. PubMed ID: 9219147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine for the treatment of cocaine and methamphetamine dependence.
    Galloway GP; Newmeyer J; Knapp T; Stalcup SA; Smith D
    J Addict Dis; 1994; 13(4):201-16. PubMed ID: 7734470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
    Benkert O; Gründer G; Wetzel H; Hackett D
    J Psychiatr Res; 1996; 30(6):441-51. PubMed ID: 9023787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
    Nunes EV; McGrath PJ; Quitkin FM; Ocepek-Welikson K; Stewart JW; Koenig T; Wager S; Klein DF
    Drug Alcohol Depend; 1995 Oct; 39(3):185-95. PubMed ID: 8556967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loading dose imipramine--new approach to pharmacotherapy of melancholic depression.
    Malhotra S; Santosh PJ
    J Psychiatr Res; 1996; 30(1):51-8. PubMed ID: 8736467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial.
    Cheong PK; Ford AC; Cheung CKY; Ching JYL; Chan Y; Sung JJY; Chan FKL; Wu JCY
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):837-844. PubMed ID: 30361080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
    Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P
    Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: a double-blind clinical trial.
    Abedin Zadeh M; Moslemi MK; Kholaseh Zadeh G
    J Pediatr Urol; 2011 Feb; 7(1):30-3. PubMed ID: 20399146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The world of the Haight-Ashbury speed freak.
    Smith RC; Crim D
    J Psychoactive Drugs; 2011; 43(2):165-71. PubMed ID: 21858962
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy side effects.
    Markowitz J; Patrick K
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):842. PubMed ID: 8768342
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence.
    Heinzerling KG; Gadzhyan J; van Oudheusden H; Rodriguez F; McCracken J; Shoptaw S
    J Adolesc Health; 2013 Apr; 52(4):502-5. PubMed ID: 23333007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.